Amvuttra 25 mg/0.5 mL prefilled syringe Images
Generic Name: vutrisiran
This medication has been identified as Amvuttra 25 mg/0.5 mL prefilled syringe. It is supplied by Alnylam Pharmaceuticals, Inc.
Amvuttra is used in the treatment of Hereditary Amyloidosis and belongs to the drug class miscellaneous metabolic agents. Amvuttra 25 mg/0.5 mL prefilled syringe is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
More about Amvuttra (vutrisiran)
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous metabolic agents
- En español
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.